Oklo shares surge on upgraded price target by B. Riley
Investing.com -- Shares of Oklo (NYSE: OKLO) surged 21% following an upgraded price target from B. Riley analyst Ryan Pfingst. The analyst raised the target to $58 from $27 while maintaining a Buy ...
As US Supreme Court girds for Trump cases, can it be an 'effective firewall'?
"The Trump administration is gambling that the court won't be an effective firewall, and the administration has decent odds ...
Egypt galvanizes Arab momentum against Trump's Gaza plan
Trump has suggested the U.S. take control of Gaza from Israel and create a "Riviera of the Middle East" after resettling ...
Fitch reaffirms EU and Euratom 'AAA' ratings, anticipates stable outlook
Investing.com -- Fitch Ratings has confirmed the Long-Term Issuer Default Ratings (IDR) of the European Union (EU) and European Atomic Energy Community (Euratom) at 'AAA' with Stable Outlooks, ...
CSL Behring confirms long-term efficacy of HEMGENIX in hemophilia B treatment
Data from the study showed that HEMGENIX continues to deliver sustained factor IX activity levels for up to four years post-treatment. The treatment also provides long-term bleed protection, ...
Neurocrine Biosciences stock falls on revenue miss
Investing.com -- Shares of Neurocrine (NASDAQ: NBIX) Biosciences (NASDAQ: NBIX) tumbled 11% as the company reported revenues that fell short of estimates. Despite reporting a 26% growth in INGREZZA® ...
Bank of England's chief economist opposes hasty interest rate cut
Investing.com -- Bank of England Chief Economist Huw Pill has expressed disagreement with colleagues who are advocating for a substantial interest rate cut. Pill's argument is that the decision to ...
Genpact shares surge on upbeat earnings and guidance
Genpact's President and CEO, Balkrishan "BK" Kalra, expressed confidence in the company's trajectory, highlighting strong quarterly growth, particularly in the Data-Tech-AI segment, and a record $5.7 ...
Why Morgan Stanley says the bull case for AI/cloud capex stocks is 'bolstering'
Investing.com -- Growing capital expenditures (capex) for cloud infrastructure are expected to “bolster the bull case for AI/cloud capex stocks,” according to Morgan Stanley (NYSE: MS) analysts.
AIM ImmunoTech advances Ampligen for avian influenza vaccine
Investing.com -- AIM ImmunoTech (NYSE: AIM) Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This move is part of AIM's antiviral ...
Cantaloupe stock rises on earnings beat
Cantaloupe's second-quarter results were bolstered by a net income applicable to common shares of $5.0 million, up from $3.1 million in the prior year's quarter. The company also reported strong ...
Kolanovic calls Palantir a ‘meme mega cap’ stock
Kolanovic’s comment references the stock's rapid ascent, which has been fueled by investor enthusiasm for artificial intelligence and government contracts. Palantir, once considered a niche defense ...